Bias as a source of inconsistency in ivermectin trials for COVID-19: A systematic review. Ivermectin's suggested benefits are mainly based on potentially biased results.
J Clin Epidemiol
; 144: 43-55, 2022 04.
Article
in En
| MEDLINE
| ID: mdl-34933115
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Ivermectin
/
COVID-19 Drug Treatment
Type of study:
Clinical_trials
/
Systematic_reviews
Limits:
Humans
Language:
En
Journal:
J Clin Epidemiol
Journal subject:
EPIDEMIOLOGIA
Year:
2022
Type:
Article